Prolonged course of familial hemophagocytic lymphohistiocytosis

Journal of Pediatric Hematology/Oncology

Volumn 28, Issue 12, 2006, Pages 831-833

  Steinberg, Orna ^a   Yacobovich, Joanne ^a,b   Dgany, Orly ^a,b   Kodman, Yona ^a,b   Livni, Gilat ^a   Rachmel, Avinoam ^a   Stein, Jerry ^a,b   Yaniv, Isaac ^a   Tamary, Hannah ^a,b  

^a SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Bone marrow transplant; Familial hemophagocytic lymphohistiocytosis; PRF1 gene

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; ETOPOSIDE;

ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CASE REPORT; DISEASE COURSE; FEVER; GENE MUTATION; GENETIC HETEROGENEITY; GRAFT REJECTION; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; HEPATOSPLENOMEGALY; HOMOZYGOTE; HUMAN; LABORATORY TEST; MALE; PRIORITY JOURNAL; SCHOOL CHILD;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE MARROW TRANSPLANTATION; CHILD; HOMOZYGOTE; HUMANS; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; MALE; MUTATION; PORE FORMING CYTOTOXIC PROTEINS; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 33845703455     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e31802d3a96     Document Type: Article

References (12)

1. Henter JI, Elinder G, Ost A. Diagnostic guidelines for hemophagocytic lymphohistiocytosis. The FHL Study Group of the Histiocyte Society. Semin Oncol. 1991;18:29-33.
2. Janka GE, Schneider EM. Modern management of children with haemophagocytic lymphohistiocytosis. Br J Haematol. 2004;124:4-14.
3. Janka G, Zur Stadt U. Familial and acquired hemophagocytic lymphohistiocytosis. Hematology (Am Soc Hematol Educ Program). 2005;82-88.
4. Molleran Lee S, Villanueva J, Sumegi J, et al. Characterisation of diverse PRF1 mutations leading to decreased natural killer cell activity in North American families with hemophagocytic lymphohistiocytosis. J Med Genet. 2004;41:137-144.
5. Ueda I, Ishii E, Morimoto A, et al. Correlation between phenotypic heterogeneity and gene mutational characteristics in familial hemophagocytic lymphohystiocytosis (FHL). Pediatr Blood Cancer. 2006;46:482-488.
6. Stepp SE, Dufourcq-Lagelouse R, Le Deist F, et al. Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science. 1999;286:1957-1959.
7. Feldmann J, Le Deist F, Ouachee-Chardin M, et al. Functional consequences of perforin gene mutations in 22 patients with familial haemophagocytic lymphohistiocytosis. Br J Haematol. 2002;117:965-972.
8. Henter JI, Arico M, Egeler RM, et al. HLH-94: a treatment protocol for hemophagocytic lymphohistiocytosis. HLH study Group of the Histiocyte Society. Med Pediatr Oncol. 1997;28:342-347.
9. Allen M, De Fusco C, Legrand F, et al. Familial hemophagocytic lymphohistiocytosis: how late can the onset be? Haematologica. 2001;86:499-503.
10. Clementi R, Emmi L, Maccario R, et al. Adult onset and atypical presentation of hemophagocytic lymphohistiocytosis in siblings carrying PRF1 mutations. Blood. 2002;100:2266-2277.
11. Risma KA, Frayer RW, Filipovich AH, et al. Aberrant maturation of mutant perforin underlies the clinical diversity of hemophagocytic lymphohistiocytosis. J Clin Invest. 2006;116:182-192.
12. Sullivan KE, Delaat CA, Douglas SD, et al. Defective natural killer cell function in patients with hemophagocytic lymphohistiocytosis and in first degree relatives. Pediatr Res. 1998;44:465-468.